今日の臨床サポート 今日の臨床サポート
関連論文:
img  1:  Vaccine-preventable travel health risks: what is the evidence--what are the gaps?
 
著者: Robert Steffen, Ron H Behrens, David R Hill, Christina Greenaway, Karin Leder
雑誌名: J Travel Med. 2015 Jan-Feb;22(1):1-12. doi: 10.1111/jtm.12171. Epub 2014 Nov 6.
Abstract/Text BACKGROUND: Existing travel health guidelines are based on a variety of data with underpinning evidence ranging from high-quality randomized controlled trials to best estimates from expert opinion. For strategic guidance and to set overall priorities, data about average risk are useful. The World Health Organization (WHO) plans to base future editions of "International Travel and Health" on its new "Handbook for Guideline Development."
METHODS: Based on a systematic search in PubMed, the existing evidence and quality of data on vaccine-preventable disease (VPD) risks in travelers was examined and essentials of vaccine efficacy were briefly reviewed. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework was used to evaluate the quality of the data.
RESULTS: Moderate-quality data to determine the risk of VPD exist on those that are frequently imported, whereas in most others the level of confidence with existing data is low or very low.
CONCLUSIONS: In order for the WHO to produce graded risk statements in the updated version of "International Travel and Health," major investment of time plus additional high-quality, generalizable risk data are needed.

© 2014 International Society of Travel Medicine.
PMID 25378212  J Travel Med. 2015 Jan-Feb;22(1):1-12. doi: 10.1111/jtm.12171. Epub 2014 Nov 6.
戻る

さらなるご利用にはご登録が必要です。

こちらよりご契約または優待日間無料トライアルお申込みをお願いします。

(※トライアルご登録は1名様につき、一度となります)


ご契約の場合はご招待された方だけのご優待特典があります。

以下の優待コードを入力いただくと、

契約期間が通常12ヵ月のところ、14ヵ月ご利用いただけます。

優待コード: (利用期限:まで)

ご契約はこちらから